InVivo Therapeutics Ownership | Who Owns InVivo Therapeutics?
InVivo Therapeutics Ownership Summary
InVivo Therapeutics is owned by 0.76% institutional investors, and 99.24% retail investors. Vima is the largest institutional shareholder, holding 0% of NVIV shares. Fidelity Extended Market Index is the top mutual fund, with 0.47% of its assets in InVivo Therapeutics shares.
NVIV Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | InVivo Therapeutics | 0.76% | - | 99.24% |
Sector | Healthcare Stocks | 47.25% | 8.01% | 44.75% |
Industry | Biotech Stocks | 45.35% | 7.81% | 46.83% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Extended Market Index | 14.49K | 0.47% | - |
Fidelity Series Total Market Index | 2.42K | 0.08% | - |
Fidelity Nasdaq Composite Index | 1.76K | 0.06% | - |
NT Ext Equity Mkt Idx Fd - NL | 1.58K | 0.05% | - |
NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 1.27K | 0.04% | 2.00 |
Northern Trust Extended Eq Market Idx | 1.20K | 0.04% | - |
NT Ext Equity Mkt Idx Fd - L | 1.20K | 0.04% | - |
NT Ext Eq Mkt Indx Fd DC Lending Tier 5 | 51.00 | 0.00% | - |
InterOcean Capital Group EIO | 49.00 | 0.00% | -1.00 |
NT US Market Cap Idx Fd - L | 46.00 | 0.00% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Feb 05, 2023 | Foose Brice | - | Sell | $6.40K |
Feb 05, 2023 | Foose Brice | - | Sell | $3.90K |
Feb 05, 2023 | Foose Brice | - | Sell | $13.44K |
Feb 05, 2023 | Foose Brice | - | Sell | $3.00K |
Feb 05, 2023 | Foose Brice | - | Sell | $11.47K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2022 Q4 | - | - |
2022 Q3 | - | - |
2021 Q4 | - | - |
2021 Q2 | - | - |
2021 Q1 | - | - |
NVIV Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools